Implantable medical device with his-purkinje activity detection

• US 7,792,580 B2
• Filed: 09/21/2004
• Issued: 09/07/2010
• Est. Priority Date: 09/21/2004
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Borowitz, Lynn A., Combs, William J.
• Primary Examiner(s): Layno; Carl H
• Assistant Examiner(s): Oropeza; Frances P
• Application Number:
  US10/945,620
• Publication Number:
  US 20060064027A1
• Time in Patent Office: 2,177 Days
• Field of Search: 600508-509, 600/373, 600/374, 600/377, 600/393, 600/513, 607 4- 6, 607/9, 607/116, 607/119, 607/123
• US Class Current: 607/9
• CPC Class Codes: A61N 1/368 comprising more than one electrode co-operating with different heart regions A61N1/3622, A61N1/3627 take precedence
• CPC Class Codes: A61N 1/3682 with a variable atrioventricular delay
• CPC Class Codes: A61N 1/3702 Physiological parameters A61N1/365 takes precedence; evoked response A61N1/371

Abstract

Implantable medical devices having two or more leads can utilize digital signal processing to sample and filter the acquired data. The processed data is utilized to identify electrical activity in cardiac tissue remote from the lead location. An atrial lead and a ventricular lead are used to acquire data and the data is processed to indicated electrical timing within the HIS bundle.

Claims

1. An implantable medical device (IMD) comprising:

means for acquiring analog signals from cardiac activity;

means for converting the analog signals to digital signals;

means for processing the digital signals to identify HIS bundle electrical timing wherein the means for processing include means for subtracting a ventricular signal from an atrial signal to produce a HIS signal; and

means for computing intervals between the HIS signal and each of the ventricular and atrial signals;

means for determining the performance of the conduction system based on the monitored intervals.

2. The IMD of claim 1, wherein the means for acquiring include an atrial lead and a ventricular lead.

3. The IMD of claim 1, further comprising means for filtering the HIS signal.

4. The IMD of claim 3, wherein the means for filtering include a bandpass filter.

5. The IMD of claim 4, wherein the bandpass filter is a 30 Hz bandpass filter.

6. The IMD if claim 1, further comprising means for averaging multiple HIS signals.

7. The IMD of claim 1, where the means for converting include a 12 bit A/D converter sampling at a rate of 1 kHz or greater.

8. An implantable medical device (IMD) comprising:

a processor;

an atrial lead electrically coupled with the processor and providing analog atrial data to the processor;

a ventricular lead electrically coupled with the processor and providing analog ventricular data to the processor;

an A/D converter in electrical communication with the processor for converting the analog atrial data and analog ventricular data to digital atrial data and digital ventricular data; and

a digital signal processing module in communication with the processor, said digital signal processing module including an algorithm to subtract the ventricular signal defined by the digital ventricular data from an atrial signal defined by the digital atrial data to produce a HIS signal, wherein intervals between the HIS signal and each of the ventricular and atrial signals is monitored to determine the performance of the conduction system based on the monitored intervals.

9. A method of determining timing within a HIS bundle from an atrial and a ventricular lead, the method comprising:

sensing electrical activity within a ventricle via the ventricular lead;

sensing electrical activity with an atrium via the atrial lead;

sampling the sensed electrical activity from the atrium and from the ventricle to produce an atrial signal and a ventricular signal;

subtracting the ventricular signal from the atrial signal to produce a HIS signal;

identifying the timing of HIS electrical activity from the HIS signal; and

averaging a plurality of the identified HIS signals to establish a baseline signal;

utilizing the baseline signal to analyze a subsequent HIS signal, wherein the analysis includes monitoring intervals between the HIS signal and each of the ventricular and atrial signals to determine the performance of the conduction system.

10. The method of claim 9, further comprising averaging a plurality of HIS signals prior to identifying the timing.

11. The method of claim 9, further comprising filtering the HIS signal prior to identifying the timing.

12. The method of claim 9, further comprising:

generating a baseline complex;

comparing the HIS signal to the baseline; and

discarding the HIS signal unless the HIS signal is temporally correlated to the baseline.